Michael Orlich retweeted
Our team is hiring #Postdocs! 👩🔬🧑🔬 If you have a background in #vascularbiology, #inflammation, #cancer, or #obesity and a passion for #science, apply to join us. Full-time, 2-year position starting in 2025 #Postdoc #Science #MolecularBiology👇
tinyurl.com/CVDs-obesity
Michael Orlich retweeted
Would you like to join our lab as a PhD student? We have discovered novel specific regulators of #lymphatic or #blood #endothelium and you can help us to investigate them! uke.jobs/index.php?ac=jobad&… #vascularbiology @dzhk_germany @YoungDZHK @UKEHamburg
Michael Orlich retweeted
Here is iSuRe-HadCre ! A new tool essential for effective conditional genetics ! Many Thanks to the @CNIC_CARDIO excellent technical units and our collaborators @MarionaGraupera; @PotenteLab and @makinenlab. I hope you love it as much as we do. academic.oup.com/nar/article….
Michael Orlich retweeted
I am happy to share our now published paper on @CellReports about the repercussions of Cldn5 mosaic deletion for the blood-brain barrier in adult mice 🥳 Thanks to all co-authors for such a great job! cell.com/cell-reports/fullte…
Michael Orlich retweeted
A phosphodiesterase pathway essential for lymphangiogenic growth arrest and maturation. A preview of our recent paper on PDE2A by Kari Alitalo @Dev_Cell Thank you! #lymphatics #vascularbiology @UKEHamburg @dfg_public @dzhk_germany @YoungDZHK
sciencedirect.com/science/ar…
Michael Orlich retweeted
I am very proud to share our new work, published today @Dev_Cell. We identify a fundamental role of the #phosphodiesterase2A in #lymphatic junctional maturation. This work was a great team effort led by Claudia Carlantoni & Leon Liekfeld @UKEHamburg #vascularbiology #PDE2A #cGMP
Michael Orlich retweeted
Watch out for the Seen AngioScience Conference in September 2024! More to come soon. #seeon #angioscience #vascularbiology #vascularbiomedicine #vwfb
Michael Orlich retweeted
In our work, we performed RNA-sequencing, ATAC-seq and Bisulfite sequencing to characterise the changes in transcriptomics, chromatin landscape and methylation profiles of cerebral Endothelial Cells in the ageing mice.
Michael Orlich retweeted
Our latest story on the incongruence between transcriptional states and vascular pathophysiology @NatureCVR🍾. Thanks to all authors and collaborators @CNIC_CARDIO, @mliarispe, @KGaengel. nature.com/articles/s44161-0…
Michael Orlich retweeted
So happy that this work, many years in the making and involving multi-lab collaborations, is out in @ScienceAdvances Congrats to everyone involved! @mf_navedo @kunalraygor Special thanks to Lawrence and Feng! science.org/doi/10.1126/scia…
Michael Orlich retweeted
Would you like to start your lab set in the amazing Vascular Biology community? This is the place for you!
Less than a month left to apply!
If you have questions about the environment, facilities, start-up package, eligibility, career interruptions... DM us!
#sciencejobs
The deadline for application for the junior group leader @VascBioUpp is extended to June 5, 2023! If you would like to open your lab in a fantastic environment apply!
#vascbio #postdocjobs #newPI
👇👇👇👇
Michael Orlich retweeted
#NAVBO Member Publication Alert
Endothelial Rbpj deletion normalizes Notch4-induced brain #ArterioVenousMalformation in mice
Dr. Rong Wang group @JExpMed 2023 @Rong_A_Wang
rupress.org/jem/article/220/…
Michael Orlich retweeted
The deadline for application for the junior group leader @VascBioUpp is extended to June 5, 2023! If you would like to open your lab in a fantastic environment apply!
#vascbio #postdocjobs #newPI
👇👇👇👇
Interested in establishing your own research group in Vascular Biology?
A 6-year career-developing Associate Senior Lecturer position in an exciting & vibrant environment is now available at Uppsala University. Apply! uu.se/en/about-uu/join-us/de…
Michael Orlich retweeted
Uppsala @VascBioUpp well represented at @VACure1 VAC2023 conference in Brussels. Such an amazing opportunity to learn and make connections between basic, translational and clinical research on vascular anomalies!
Michael Orlich retweeted
In @JExpMed: new Ptx3-positive immune-interacting subtype of lymphatic endothelial cells, iLECs, drive oncogenic PI3K-driven lymphatic malformations through paracrine crosstalk involving pro-lymphangiogenic macrophages: bit.ly/3Hp8gFA
@Milena_kp @makinenlab @KraftMarle
Michael Orlich retweeted
How fat take over our lymph nodes as we age and the consequences vascular and immune functions!
Read our new story in Journal of Pathology!
Figure from supplement 9 outlining some of our findings!
onlinelibrary.wiley.com/doi/…
Great review!
Upsala Journal of Medical Sciences...IF to the moon :-D
This Post is from an account that no longer exists. Learn more
Michael Orlich retweeted
EZ Clear and Lightsheet imaging together make visualizing and investigating whole eye vasculature possible. No more flat mounting!
#EZClear #ZeissMicroscopy #lightsheet #OiVM #fluorescencemonday
Happy that our paper is finally out! ahajournals.org/doi/10.1161/… in @circres. We show that the transcription factor SRF controls pericyte migration and pathological activation in OIR. In vSMCs it controls the contractile machinery and its deletion leads to AV-shunts.
























